Magnetar Financial LLC Dexcom Inc Transaction History

Magnetar Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $30.9 Million - $39.4 Million	280,407 New	280,407 $31.8 Million
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $33.3 Million - $53.4 Million	386,809 New	386,809 $36.1 Million
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $407,366 - $563,766	-4,330 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $562,337 - $705,010	4,330 New	4,330 $2.33 Million
Q1 2021 May 14, 2021	SELL	$84.79 - $104.74 $225,710 - $278,817	-2,662 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$78.0 - $104.5 $221,520 - $296,780	-2,840 Reduced 51.62%	2,662 $984,000
Q3 2020 Nov 16, 2020	BUY	$95.51 - $112.95 $525,496 - $621,450	5,502 New	5,502 $2.27 Million

1,013

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Magnetar Financial LLC with notifications on news.